Record title

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Record identifier

TN_cdi_proquest_miscellaneous_2232119706

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2232119706

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

About this item

Full title

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2019, Vol.20 (7), p.924-937

Record Identifier

TN_cdi_proquest_miscellaneous_2232119706

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2232119706

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2232119706

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item